Cargando…

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss

Patient: Male, 59 Final Diagnosis: Olmesartan associated enteropathy Symptoms: Diarrhea and weight loss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Olmesartan, an angiotensin receptor blockade class o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonakoti, Sripriya, Khullar, Sanjiv, Rajkumar, Aarthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364444/
https://www.ncbi.nlm.nih.gov/pubmed/30683835
http://dx.doi.org/10.12659/AJCR.913207
_version_ 1783393278697144320
author Gonakoti, Sripriya
Khullar, Sanjiv
Rajkumar, Aarthi
author_facet Gonakoti, Sripriya
Khullar, Sanjiv
Rajkumar, Aarthi
author_sort Gonakoti, Sripriya
collection PubMed
description Patient: Male, 59 Final Diagnosis: Olmesartan associated enteropathy Symptoms: Diarrhea and weight loss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Olmesartan, an angiotensin receptor blockade class of antihypertensive medication has recently been associated with a seronegative sprue like enteropathy. Patients typically present with diarrhea and weight loss often prompting exhaustive diagnostic workup. Discontinuation of the drug leads to dramatic recovery and hence, physicians need to be aware of olmesartan associated enteropathy (OAE) in order to avoid unnecessary testing. CASE REPORT: A 59-year-old Caucasian male was admitted to the hospital with complaints of intractable diarrhea, vomiting and considerable weight loss. Medical history was notable for hypertension being treated with olmesartan. Workup for all potential infectious causes and celiac disease was negative. Eventually, a colonoscopy was performed due to his persistent symptoms and biopsy revealed lymphocytic colitis. An upper endoscopy was also performed, and histopathology of the duodenum revealed total villous blunting. In light of negative serology for celiac disease and after a detailed review of the patient’s medications, the possibility of olmesartan induced enteropathy was considered. Olmesartan was stopped and his symptoms resolved. A follow-up endos-copy done a few months later showed normal small bowel mucosa. CONCLUSIONS: This case demonstrates the need for a thorough medication review by healthcare providers especially after a full workup for the patient’s symptoms has already been performed. It also reiterates that having an awareness of rare side effects of common medications mitigates the need for extensive diagnostic testing.
format Online
Article
Text
id pubmed-6364444
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-63644442019-02-15 Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss Gonakoti, Sripriya Khullar, Sanjiv Rajkumar, Aarthi Am J Case Rep Articles Patient: Male, 59 Final Diagnosis: Olmesartan associated enteropathy Symptoms: Diarrhea and weight loss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Olmesartan, an angiotensin receptor blockade class of antihypertensive medication has recently been associated with a seronegative sprue like enteropathy. Patients typically present with diarrhea and weight loss often prompting exhaustive diagnostic workup. Discontinuation of the drug leads to dramatic recovery and hence, physicians need to be aware of olmesartan associated enteropathy (OAE) in order to avoid unnecessary testing. CASE REPORT: A 59-year-old Caucasian male was admitted to the hospital with complaints of intractable diarrhea, vomiting and considerable weight loss. Medical history was notable for hypertension being treated with olmesartan. Workup for all potential infectious causes and celiac disease was negative. Eventually, a colonoscopy was performed due to his persistent symptoms and biopsy revealed lymphocytic colitis. An upper endoscopy was also performed, and histopathology of the duodenum revealed total villous blunting. In light of negative serology for celiac disease and after a detailed review of the patient’s medications, the possibility of olmesartan induced enteropathy was considered. Olmesartan was stopped and his symptoms resolved. A follow-up endos-copy done a few months later showed normal small bowel mucosa. CONCLUSIONS: This case demonstrates the need for a thorough medication review by healthcare providers especially after a full workup for the patient’s symptoms has already been performed. It also reiterates that having an awareness of rare side effects of common medications mitigates the need for extensive diagnostic testing. International Scientific Literature, Inc. 2019-01-26 /pmc/articles/PMC6364444/ /pubmed/30683835 http://dx.doi.org/10.12659/AJCR.913207 Text en © Am J Case Rep, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Gonakoti, Sripriya
Khullar, Sanjiv
Rajkumar, Aarthi
Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title_full Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title_fullStr Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title_full_unstemmed Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title_short Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
title_sort olmesartan associated enteropathy: a rare underdiagnosed cause of diarrhea and weight loss
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364444/
https://www.ncbi.nlm.nih.gov/pubmed/30683835
http://dx.doi.org/10.12659/AJCR.913207
work_keys_str_mv AT gonakotisripriya olmesartanassociatedenteropathyarareunderdiagnosedcauseofdiarrheaandweightloss
AT khullarsanjiv olmesartanassociatedenteropathyarareunderdiagnosedcauseofdiarrheaandweightloss
AT rajkumaraarthi olmesartanassociatedenteropathyarareunderdiagnosedcauseofdiarrheaandweightloss